MITHRA PHARMACEUTICALS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.216 EUR | -1.82% |
|
-3.57% | -82.78% |
| 04-22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
| 03-08 | Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Mithra Pharmaceuticals S.A.
da79b0ea58edb.jPAi2URbvtuhjN-LTx9jyHyPKpS86_y2Ts6oHduLP_0.u5xQtTw_zIrTyrnZeCYil0veYviNhsj9AY_QL5jZW768tU69AWyOv5besA~69c3e9c4deda64543b469e0300ab96f4
Upcoming events on Mithra Pharmaceuticals S.A.
Past events on Mithra Pharmaceuticals S.A.
| 08/03/2024 06:00 | Q4 2023 Earnings Release |
| 23/11/2023 13:00 | Extraordinary Shareholders Meeting - Second |
| 30/10/2023 13:00 | Extraordinary Shareholders Meeting - First |
| 26/09/2023 13:00 | Q2 2023 Earnings Call |
| 26/09/2023 06:00 | Q2 2023 Earnings Release |
| 25/05/2023 13:00 | Annual General Meeting |
| 22/05/2023 | Euronext Nordic Investor Conference |
| 24/04/2023 | Kempen Lifesciences Conference |
| 13/03/2023 | Berenberg EU Opportunities Conference |
| 07/03/2023 08:00 | Q4 2022 Earnings Call |
| 07/03/2023 06:30 | Q4 2022 Earnings Release |
| 20/11/2022 | Life Sciences Day Digital Conference |
| 03/10/2022 | Portzamparc BNP Paribas Biotech & Health Conference |
| 23/09/2022 08:00 | Interim 2022 Earnings Call |
| 23/09/2022 06:30 | Interim 2022 Earnings Release |
| 18/05/2022 | Annual General Meeting |
| 14/03/2022 | Berenberg Bank EU Opportunities Conference |
| 08/03/2022 08:00 | FY 2021 Earnings Call |
| 07/03/2022 | FY 2021 Earnings Release |
| 05/12/2021 | Berenberg European Conference |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 65,5 67,8 -3.49% | 96,5 79,4 21.54% | 9,03 29,6 -69.53% | 22,7 47,8 -52.6% | 67,0 52,2 28.27% | 40,2 36,5 10.16% |
|
EBITDA Million EUR | Released Forecast Spread | 38,3 0,00 - | 31,8 51,0 -37.6% | -73,8 -43,0 -71.64% | -77,5 -66,6 -16.29% | -14,3 -64,0 77.65% | -52,8 -53,8 1.91% |
|
EBIT Million EUR | Released Forecast Spread | 35,5 22,8 55.85% | 35,0 3,55 885.18% | -79,9 -51,0 -56.75% | -87,9 -65,0 -35.23% | -26,2 -56,9 53.85% | -139 -50,7 -174.42% |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -16,2 14,2 -214.32% | -40,4 38,0 -206.18% | -111 -53,0 -109.29% | -124 -94,3 -31.19% | -11,5 -110 89.56% | -162 -87,3 -85.33% |
|
Net income Million EUR | Released Forecast Spread | -12,4 25,1 -149.25% | -26,6 -16,8 -58.02% | -92,1 -27,7 -233.04% | -117 -75,5 -54.82% | -59,6 -80,9 26.31% | -174 -63,9 -171.52% |
|
EPS EUR | Released Forecast Spread | -0,33 0,00 - | -0,70 -0,53 -31.29% | -2,25 -0,69 -224.25% | -2,69 -1,77 -51.88% | -1,22 -1,20 -2.09% | 0,00 -1,39 - |
| Announcement Date | 01/03/19 | 09/03/20 | 09/03/21 | 08/03/22 | 07/03/23 | 08/03/24 |
Quarterly results
| Fiscal Period | December | 2023 Q2 |
|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 7,04 |
|
Net income Million EUR | Released Forecast Spread | -50,5 |
| Announcement Date | 26/09/23 |
More events
Past sector events for Mithra Pharmaceuticals S.A.
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MITRA Stock
- Calendar Mithra Pharmaceuticals S.A.
